Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Zhiguang Zhou"'
Autor:
Fen Liu, Ting Li, Dandan Li, Hairong Luo, Shaojie Yu, Lei Song, Bilian Liu, Zixin Cai, Shanbiao Hu, Jingjing Zhang, Yan Yang, Weiping Zhang, Zhiguang Zhou
Publikováno v:
Journal of Genetics and Genomics. 49:208-216
Decreased functional β-cell mass is the hallmark of diabetes, but the cause of this metabolic defect remains elusive. Here, we show that the expression levels of the growth factor receptor-bound protein 10 (GRB10), a negative regulator of insulin an
Publikováno v:
Diabetes, obesitymetabolismREFERENCES. 25(2)
To investigate the impact of family history of type 2 diabetes (T2D) on the clinical phenotypes of patients with idiopathic type 1 diabetes (T1D).In clinically diagnosed T1D cases, a total of 335 idopathic T1D patients were included in the study, aft
Autor:
Fen Liu, Zixin Cai, Yan Yang, George Plasko, Piao Zhao, Xiangyue Wu, Cheng Tang, Dandan Li, Ting Li, Shanbiao Hu, Lei Song, Shaojie Yu, Ran Xu, Hairong Luo, Libin Fan, Ersong Wang, Zhen Xiao, Yujiao Ji, Rong Zeng, Rongxia Li, Juli Bai, Zhiguang Zhou, Feng Liu, Jingjing Zhang
Publikováno v:
Science advances. 8(38)
Pancreatic β cell failure is a hallmark of diabetes. However, the causes of β cell failure remain incomplete. Here, we report the identification of tetranectin (TN), an adipose tissue–enriched secretory molecule, as a negative regulator of insuli
Autor:
Lu Lin, Tuanyu Fang, Zhiguang Zhou, Qianying Ou, Huachuan Zhang, Leweihua Lin, Huibiao Quan, Kaining Chen
Publikováno v:
International Journal of Diabetes in Developing Countries. 42:218-226
Fasting proinsulin/fasting insulin, proinsulin/insulin, vitamin D3, and waistline are each associated with the risk of diabetes. The aim of this study was to explore the effects of fasting proinsulin/fasting insulin, proinsulin/insulin, vitamin D3, a
Autor:
Zhiguang Zhou, Lu Lin, Leweihua Lin, Huachuan Zhang, Huibiao Quan, Qianying Ou, Tuanyu Fang, Kaining Chen
Publikováno v:
Diabetes Therapy
Introduction Diabetes mellitus (DM) has a serious impact on people’s lives in the world. Interventions that affect risk factors for prediabetes can prevent and reduce diabetes occurrence. Proinsulin (PI), true insulin (TI), and proinsulin to insuli
Publikováno v:
Frontiers in immunology. 13
Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease with insulin deficiency due to pancreatic β cell destruction. Multiple independent cohort studies revealed specific lipid spectrum alterations prior to islet autoimmunity in T1DM. Excep
Autor:
Keyu, Guo, Jianan, Ye, Liyin, Zhang, Qi, Tian, Li, Fan, Zhiyi, Ding, Qin, Zhou, Xia, Li, Zhiguang, Zhou, Lin, Yang
Publikováno v:
Frontiers in Endocrinology. 13
AimsThere is limited evidence that evaluates the glycemic control of type 1 diabetes mellitus (T1DM) during the Chinese New Year public holiday in China. The Chinese New Year public holiday represents various challenges to glycemic control, especiall
Publikováno v:
Frontiers in Endocrinology. 13
BackgroundLatent autoimmune diabetes in adults (LADA) is a heterogeneous form of diabetes, characterized by autoimmune destruction of pancreatic β-cells as well as insulin resistance and is triggered by environmental factors in the context of geneti
Autor:
Siyun Liu, Hai-Lan Zou, Zhiguang Zhou, Hongjuan Wang, Jia Guo, Yang Xiao, Lili Liu, Chao Deng, Yixuan Xing
Publikováno v:
Journal of Diabetes Investigation, Vol 12, Iss 4, Pp 546-556 (2021)
Journal of Diabetes Investigation
Journal of Diabetes Investigation
Aims/Introduction Several clinical trials reported the effects of sodium–glucose cotransporter (SGLT) inhibitors in type 1 diabetes patients. This meta‐analysis aimed to assess the efficacy and safety of SGLT inhibitors in type 1 diabetes patient
Publikováno v:
Frontiers in endocrinology. 13
Diabetes mellitus (DM) is an endocrine disorder characterized by a relative or absolute lack of insulin due to the dysfunction or destruction of β-cells. DM is one of the fastest growing challenges to global health in the 21st century and places a t